[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100418122":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":10,"locations":18,"responsibleParty":37,"collaborators":10,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":41,"sex":46,"minAge":10,"maxAge":10,"enrollmentInfo":47,"targetDuration":10,"studyType":50,"phases":10,"briefSummary":51,"conditions":52,"keywords":55,"overallStatus":20,"whyStopped":10,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Hospices Civils de Lyon","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"patients having had avderse event after phagotherapy for bone or joint infection",null,[12],"Other: patients having had avderse event after phagotherapy for bone or joint or implant infection",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":10},"patients having had avderse event after phagotherapy for bone or joint or implant infection","to determine the accountability of adverse effects in having had avderse event after phagotherapy for bone or joint or implant infection",[9],[19],{"facility":5,"status":20,"city":21,"state":10,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"RECRUITING","Lyon","69004","France","FR",{"type":26,"coordinates":27},"Point",[28,29],4.84789,45.74906,{"lat":29,"lon":28},[32],{"name":33,"role":34,"phone":35,"phoneExt":10,"email":36},"Johanna Boulant, CRA","CONTACT","04 26 73 29 38","johanna.boulant@chu-lyon.fr",{"type":38,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100418122","phage-safety-retrospective-cohort-study-100418122",false,"NCT04724603","Phage Safety Retrospective Cohort Study","PHASACO-retro","Inclusion Criteria:\n\n* patients having had a bone or joint or implant infection treated by phagotherapy and having had an adverse event\n\nExclusion Criteria:\n\n\\-","ALL",{"count":48,"type":49},25,"ESTIMATED","OBSERVATIONAL","The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.",[53,54],"Bone and Joint Infection","Prosthetic Joint Infection",[56,57,58,54],"bone and joint infection","phagotherapy","adverse event","2023-04-12",{"date":61,"type":62},"2023-04-13","ACTUAL",{"date":64,"type":62},"2021-02-01",{"date":66,"type":49},"2026-09-01",{"name":5,"class":6},1]